Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants. Lifecare ASA was founded in 2006 and is headquartered in Bergen, Norway.
Metrics to compare | LIFEA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIFEAPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.7x | −3.3x | −0.5x | |
PEG Ratio | 0.07 | −0.03 | 0.00 | |
Price/Book | 3.9x | 5.2x | 2.6x | |
Price / LTM Sales | 22.6x | 5.9x | 3.3x | |
Upside (Analyst Target) | 118.2% | 39.0% | 43.4% | |
Fair Value Upside | Unlock | 5.4% | 7.1% | Unlock |